stockrowAlkermes plc
ALKS Healthcare Drug Manufacturers Specialty & Generic
Alkermes plc’s revenue for fiscal 2025 (year ended December 2025) was $1.5 billion, down 5.25% from fiscal 2024.
- Revenue
- +21.8%
- EPS
- −80.6%
- Free cash flow
- +6.78%
Quarter to September 2026, against a year earlier
Follow ALKS
Alert me
Alkermes plc (ALKS) Total debt
Alkermes plc's total debt at the end of fiscal 2023 was $290.7M, unchanged from fiscal 2022. At the end of the quarter to 30 September 2026 it was $1.5B. Over the past ten years it has ranged from $275.0M (fiscal 2020) to $349.9M (fiscal 2015); the current reading is higher than 67% of that period. Alkermes plc ranks 10th of 84 Drug Manufacturers Specialty & Generic companies by total debt.
Total debt, annual
Embed this chart
Annual newest first
| Period | Total debt | Change |
|---|---|---|
| FY2023 | $290.7M | (0.87%) |
| FY2022 | $293.3M | (0.86%) |
| FY2021 | $295.8M | 7.58% |
| FY2020 | $275.0M | (0.79%) |
| FY2019 | $277.1M | (0.78%) |
| FY2018 | $279.3M | (0.76%) |
| FY2017 | $281.4M | (0.79%) |
| FY2016 | $283.7M | (18.94%) |
| FY2015 | $349.9M | — |
Quarterly newest first
| Period | Total debt | Change |
|---|---|---|
| Sep 2026 | $1.5B | (0.36%) |
| Jun 2026 | $1.5B | (0.48%) |
| Mar 2026 | $1.5B | 422.93% |
| Sep 2024 | $288.8M | (0.22%) |
| 38 more quarters | Free account |
Against its own ten years
Total debt against peers
| Company | Total debt |
|---|---|
| ELAN Elanco Animal Health Incorporated compare | $3.9B |
| AMRX AMNEAL PHARMACEUTICALS, INC. compare | $3.2B |
| ALKS Alkermes plc | $1.5B |
| HIMS Hims & Hers Health, Inc. compare | $1.4B |
| RDY Dr. Reddy's Laboratories Ltd compare | $753.0M |
| LNTH Lantheus Holdings, Inc. compare | $571.7M |
| SUPN Indivior Pharmaceuticals Inc. compare | $488.0M |
| LQDA Liquidia Corporation compare | $176.1M |
| KNSA Kiniksa Pharmaceuticals International, plc compare | $13.0M |
What Total debt is
Total Debt tells an investor how much a company has borrowed in all, whether the money is due within a year or later.
Long Term Debt (Total) + Current Part of Debt
More on ALKS
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement